Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fitscha

Showing results (51-60 of 129) with videos related to

Pageof 13
Sort By:
Progress in Clinical and Biological Research|January 1, 1987
The intrainfusion rebound platelet activation during continuous prostaglandin I2 infusion occurs at the receptor levelH Sinzinger, G Steurer, P Fitscha, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1988
20 mg aspirin daily--evidence for a clinical future of this extremely low-dose in arterial disease?H Sinzinger, K Silberbauer, J Kaliman, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|October 19, 2000
Prostaglandin E1-therapy reduces circulating adhesion molecules (ICAM-1, E-selectin, VCAM-1) in peripheral vascular diseaseB Palumbo, A Oguogho, P Fitscha, et al.
Lancet (London, England)|November 24, 1984
Effect of epoprostenol on platelet deposition on synthetic artery graftsH Sinzinger, J O'Grady, P Fitscha, et al.
Thrombosis Research|May 15, 1989
Isradipine: a potent calcium blocker with beneficial effects on platelet function and vascular prostacyclin productionK Weiss, P Fitscha, J O'Grady, et al.
Progress in Clinical and Biological Research|January 1, 1987
Beneficial effect of prostaglandin E1 on smooth muscle cell proliferationH Sinzinger, P Fitscha, T Zidek, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Effects of taprostene, a stable prostacyclin analogue, on haemodynamics, platelet function and arachidonate metabolism in healthy volunteersI Virgolini, P Fitscha, H Sinzinger, et al.
Acta Medica Austriaca|January 1, 1982
[Value of the detection of arteriosclerotic lesions with labeled autologous thrombocytes]H Sinzinger, K Silberbauer, P Fitscha, et al.
Thrombosis Research|September 1, 1989
Effects of Hydergine on platelet deposition on "active" human carotid artery lesions and platelet functionG Steurer, P Fitscha, K Ettl, et al.
The New England Journal of Medicine|October 18, 1984
Extremely-low-dose aspirin (1 mg per day) renders human platelets more sensitive to antiaggregation prostaglandinsH Sinzinger, J O'Grady, P Fitscha, et al.
Pageof 13

Showing results (51-60 of 129) with videos related to

Sort By:
Pageof 13
Progress in Clinical and Biological Research|January 1, 1987
The intrainfusion rebound platelet activation during continuous prostaglandin I2 infusion occurs at the receptor levelH Sinzinger, G Steurer, P Fitscha, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1988
20 mg aspirin daily--evidence for a clinical future of this extremely low-dose in arterial disease?H Sinzinger, K Silberbauer, J Kaliman, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|October 19, 2000
Prostaglandin E1-therapy reduces circulating adhesion molecules (ICAM-1, E-selectin, VCAM-1) in peripheral vascular diseaseB Palumbo, A Oguogho, P Fitscha, et al.
Lancet (London, England)|November 24, 1984
Effect of epoprostenol on platelet deposition on synthetic artery graftsH Sinzinger, J O'Grady, P Fitscha, et al.
Thrombosis Research|May 15, 1989
Isradipine: a potent calcium blocker with beneficial effects on platelet function and vascular prostacyclin productionK Weiss, P Fitscha, J O'Grady, et al.
Progress in Clinical and Biological Research|January 1, 1987
Beneficial effect of prostaglandin E1 on smooth muscle cell proliferationH Sinzinger, P Fitscha, T Zidek, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Effects of taprostene, a stable prostacyclin analogue, on haemodynamics, platelet function and arachidonate metabolism in healthy volunteersI Virgolini, P Fitscha, H Sinzinger, et al.
Acta Medica Austriaca|January 1, 1982
[Value of the detection of arteriosclerotic lesions with labeled autologous thrombocytes]H Sinzinger, K Silberbauer, P Fitscha, et al.
Thrombosis Research|September 1, 1989
Effects of Hydergine on platelet deposition on "active" human carotid artery lesions and platelet functionG Steurer, P Fitscha, K Ettl, et al.
The New England Journal of Medicine|October 18, 1984
Extremely-low-dose aspirin (1 mg per day) renders human platelets more sensitive to antiaggregation prostaglandinsH Sinzinger, J O'Grady, P Fitscha, et al.
Pageof 13